Atriopeptin II relaxes and elevates cGMP in bovine pulmonary artery but not vein.

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Journal of applied physiology

• Publication date

  1986-04-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1152/JAPPL.1986.60.4.1128PMID 3009386
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differences in responsiveness of intrapulmonary artery and vein to arachidonic acid: mechanism of arterial relaxation involves cyclic guanosine 3':5'-monophosphate and cyclic adenosine 3':5'-monophosphate.

  1985cited by this paper
• The pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation.

  1985cited by this paper
• Cyclic guanosine monophosphate mediates vascular relaxation induced by atrial natriuretic factor.

  1985cited by this paper
• Stimulation of coronary guanylate cyclase by nicorandil (SG-75) as a mechanism of its vasodilating action.

  1985cited by this paper
• The increase of cGMP by atrial natriuretic factor correlates with the distribution of particulate guanylate cyclase

  1985cited by this paper
• Association between cyclic GMP accumulation and acetylcholine-elicited relaxation of bovine intrapulmonary artery.

  1984cited by this paper
• Vasodilator profile of synthetic atrial natriuretic factor.

  1984cited by this paper
• The role of endothelium in the responses of vascular smooth muscle to drugs.

  1984cited by this paper
• Relaxation of intrapulmonary artery and vein by nitrogen oxide-containing vasodilators and cyclic GMP.

  1984cited by this paper
• Atrial natriuretic factor elicits an endothelium-independent relaxation and activates particulate guanylate cyclase in vascular smooth muscle.

  1984cited by this paper
• Atrial natriuretic factor selectively activates particulate guanylate cyclase and elevates cyclic GMP in rat tissues.

  1984cited by this paper
• Possible role for cyclic GMP in endothelium-dependent relaxation of rabbit aorta by acetylcholine. Comparison with nitroglycerin.

  1983cited by this paper
• Agonist‐Induced Endothelium‐Dependent Relaxation in Rat Thoracic Aorta May Be Mediated through cGMP

  1983cited by this paper
• Endothelium-dependent relaxation of rabbit aorta. I. Relaxation stimulated by arachidonic acid.

  1983cited by this paper
• Endothelium-induced relaxation by acetylcholine associated with larger rises in cyclic GMP in coronary arterial strips.

  1982cited by this paper
• Vasodilator actions of several N-nitroso compounds.

  1982cited by this paper
• Endothelium-dependent inhibitory effects of acetylcholine, adenosine triphosphate, thrombin and arachidonic acid in the canine femoral artery.

  1982cited by this paper
• Relationship between cyclic guanosine 3':5'-monophosphate formation and relaxation of coronary arterial smooth muscle by glyceryl trinitrate, nitroprusside, nitrite and nitric oxide: effects of methylene blue and methemoglobin.

  1981cited by this paper
• Methylene blue inhibits coronary arterial relaxation and guanylate cyclase activation by nitroglycerin, sodium nitrite, and amyl nitrite.

  1981cited by this paper
• Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates.

  1981cited by this paper
• Relaxation of bovine coronary arterial smooth muscle by cyclic GMP, cyclic AMP and analogs.

  1980cited by this paper
• The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

  1980cited by this paper
• Coronary arterial relaxation and guanylate cyclase activation by cigarette smoke, N'-nitrosonornicotine and nitric oxide.

  1980cited by this paper
• The effects of Mif-I on in vitro c-GMP production by a particulate rat brain fraction.

  1980cited by this paper
• Evidence for cyclic GMP-mediated relaxant effects of nitro-compounds in coronary smooth muscle

  1979cited by this paper
• Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and a carcinogenic nitrosoamine.

  1979cited by this paper
• Restoration of the responsiveness of purified guanylate cyclase to nitrosoguanidine, nitric oxide, and related activators by heme and hemeproteins. Evidence for involvement of the paramagnetic nitrosyl-heme complex in enzyme activation.

  1978cited by this paper
• Nitric oxide activates guanylate cyclase and increases guanosine 3':5'-cyclic monophosphate levels in various tissue preparations.

  1977cited by this paper
• Sodium nitroprusside and other smooth muscle-relaxants increase cyclic GMP levels in rat ductus deferens

  1977cited by this paper
• Calcium-independent modulation of cyclic GMP and activation of guanylate cyclase by nitrosamines.

  1976cited by this paper

• contraction in acute alveolar hypoxia Atrial natriuretic peptide levels and plasma volume

  2015cites this paper
• Stable Precursor Fragments of Vasoactive Peptides in Umbilical Cord Blood of Term and Preterm Infants

  2011cites this paper
• C-type natriuretic peptide regulation of guanosine-3',5'-cyclic monophosphate production in human endothelial cells.

  2010cites this paper
• Hemodynamic and humoral effects of atrial natriuretic peptide on pulmonary circulation after cardiac surgery

  2008cites this paper
• An indirect calorimetry system for ventilator dependent very low birthweight infants

  2007cites this paper
• Raised circulating plasma levels of atrial natriuretic peptide in adolescent and adult patients with cystic fibrosis and pulmonary artery hypertension

  2007cites this paper
• Role of veins in regulation of pulmonary circulation.

  2005cites this paper
• Atrial natriuretic peptide ameliorates hypoxic pulmonary vasoconstriction without influencing systemic circulation.

  2003cites this paper
• Natriuretic peptides after pulmonary resection.

  2002cites this paper
• Atrial natriuretic peptide improves pulmonary gas exchange by reducing extravascular lung water in canine model with oleic acid-induced pulmonary edema

  2002cites this paper
• Differential responses of newborn pulmonary arteries and veins to atrial and C-type natriuretic peptides.

  2002cites this paper
• L-NAME enhances responses to atrial natriuretic peptide in the pulmonary vascular bed of the cat.

  2001cites this paper
• Cell Culture Studies of Oxygen, Nitric Oxide, and Retinal Pericytes’ Contractile Tone

  2000cites this paper
• Atrial natriuretic peptide levels and plasma volume contraction in acute alveolar hypoxia.

  1997cites this paper
• ANF system in the newborn piglet pulmonary vessels.

  1997cites this paper
• Oxygen modulation of guanylate cyclase-mediated retinal pericyte relaxations with 3-morpholino-sydnonimine and atrial natriuretic peptide.

  1997cites this paper
• Acute alveolar hypoxia increases blood-to-tissue albumin transport: role of atrial natriuretic peptide.

  1997cites this paper
• Mediators, cytokines, and growth factors in liver-lung interactions.

  1996cites this paper
• The effect of atrial natriuretic peptide on pulmonary acid injury in a pig model.

  1996cites this paper
• Role of atrial natriuretic factor in lung physiology and pathology.

  1995cites this paper
• Pharmacological and physiological significance of ion channels and factors that modulate them in vascular tissues.

  1995cites this paper
• Hemodynamic Control of Atrial Natriuretic Peptide Plasma Levels in Neonatal Respiratory Distress Syndrome

  1995cites this paper
• Selective and tone-dependent vasodilation of arterial segment in rabbit and feline pulmonary microcirculation in response to ANP.

  1993cites this paper
• Atrial natriuretic peptide improves pulmonary gas exchange in subjects exposed to hypoxia.

  1993cites this paper
• Cardiopulmonary responses to chronic hypoxia in transgenic mice that overexpress ANP.

  1993cites this paper
• Chronic fatigue syndrome: a joint paediatric-psychiatric approach.

  1992cites this paper
• Atrial natriuretic peptide.

  1992cites this paper
• Comparative effects of endothelin (ET-1) and U46619 on human saphenous vein and gastroepiploic artery, sources of human autologous grafts

  1992cites this paper
• Methylene blue inhibits neurogenic cholinergic vasodilator responses in the pulmonary vascular bed of the cat.

  1992cites this paper
• Preexisting cardiopulmonary disease attenuating the atrial natriuretic peptide response. Results in patients with acute respiratory failure.

  1992cites this paper
• Plasma atrial natriuretic factor concentrations in a canine model of right heart pressure overload.

  1991cites this paper
• Relaxant effects of α‐human atrial natriuretic peptide on venous smooth muscle

  1991cites this paper
• Relaxant effects of alpha-human atrial natriuretic peptide on venous smooth muscle.

  1991cites this paper
• Atrial natriuretic peptide in acute hypoxia-induced pulmonary hypertension in rats.

  1991cites this paper
• Functional antagonism in rabbit pulmonary veins contracted by endothelin.

  1991cites this paper
• Pulmonary vasorelaxant activity of atrial peptides.

  1990cites this paper
• Atrial natriuretic peptides in canine hypoxic pulmonary vasoconstriction.

  1990cites this paper
• Atrial natriuretic peptide is a regulator of pulmonary vascular tone. A hypothesis.

  1990cites this paper
• Age-related changes in relaxant response of vascular smooth muscles to atrial natriuretic peptide.

  1990cites this paper
• Atrial natriuretic factor recognizes two receptor subtypes in endothelial cells cultured from bovine pulmonary artery

  1990cites this paper
• Atrial natriuretic peptide clearance receptor agonist lowers pulmonary pressure in hypoxic rats.

  1990cites this paper
• Sympathectomy Fails to Reveal Prominent Vasodilation by Atrial Natriuretic Factor

  1990influential citation
• Pulmonary venous responses to thromboxane A2 analogue and atrial natriuretic peptide in lambs.

  1990cites this paper
• Differential patterns of relaxation by synthetic atrial peptide (APII) in the pulmonary artery, ascending and distal abdominal aorta.

  1990cites this paper
• Developmental Changes in Sodium Nitroprusside and Atrial Natriuretic Factor Mediated Relaxation in the Guinea Pig Aorta

  1990cites this paper
• Atrial natriuretic peptide attenuates the development of pulmonary hypertension in rats adapted to chronic hypoxia.

  1990cites this paper
• Cyclic GMP: a potential mediator of neurally- and drug-induced relaxation of opossum lower esophageal sphincter.

  1989cites this paper
• Effect of exercise, hyperpnea, and bronchoconstriction on plasma atrial natriuretic peptide.

  1989cites this paper
• EFFECTS OF ATRIAL NATRIURETIC FACTOR ON CYCLIC GMP CONTENT IN THE RAT AORTIC SMOOTH MUSCLE: STUDIES ON THE ROLE OF MEMBRANE Na+,K+‐ATPase

  1989cites this paper
• Vasopressin lowers pulmonary artery pressure in hypoxic rats by releasing atrial natriuretic peptide.

  1989cites this paper
• Pulmonary vasodilator responses to atrial natriuretic factor and sodium nitroprusside.

  1989cites this paper
• Pulmonary and pleural complications of cardiac disease.

  1989cites this paper
• Biological Actions and Properties of Endothelium-Derived Nitric Oxide Formed and Released From Artery and Vein

  1989cites this paper
• Sustained dilatation of large coronary artery by alpha-human atrial natriuretic peptide in conscious dogs: a comparison with nitroglycerin.

  1989cites this paper
• Atrial natriuretic peptide lowers pulmonary arterial pressure in patients with high altitude disease.

  1989cites this paper
• Heterogeneity in responses of isolated monkey arteries and veins to atrial natriuretic peptide.

  1989cites this paper
• Atrial natriuretic factor in chronic obstructive lung disease with pulmonary hypertension. Physiological correlates and response to peptide infusion.

  1989cites this paper
• Alveolar hypoxia is a powerful stimulus for ANF release in conscious lambs.

  1989cites this paper
• Pulmonary vascular reactivity.

  1988cites this paper
• Atrial natriuretic factor attenuates the pulmonary pressor response to hypoxia.

  1988cites this paper
• Elevated plasma atrial natriuretic factor and vasopressin in high-altitude pulmonary edema.

  1988cites this paper
• Cyclic GMP affecting the tracheal nonadrenergic noncholinergic inhibitory system.

  1988cites this paper
• Cyclic Guanosine Monophosphate‐Enhanced Sequestration of Ca2+ by Sarcoplasmic Reticulum in Vascular Smooth Muscle

  1988cites this paper
• Atrial natriuretic peptide gene expression and its secretion by pneumocytes derived from neonatal rat lungs.

  1988cites this paper
• Vasodilator responses to alpha-human-atrial natriuretic peptide in isolated omental and pulmonary arteries from rabbit and man.

  1988cites this paper
• Endothelium-derived relaxing factor and nitric oxide possess identical pharmacologic properties as relaxants of bovine arterial and venous smooth muscle.

  1988cites this paper
• Atrial natriuretic peptide concentrations and pulmonary hemodynamics in patients with pulmonary artery hypertension.

  1987cites this paper
• Pharmacologic effects of atrial natriuretic peptide.

  1987cites this paper
• The actions of atrial natriuretic factor on the vascular wall.

  1987cites this paper
• A comparison of the vasodilator responses to atrial peptides in the pulmonary and renal arteries of the pig in vitro

  1987cites this paper